Phase II Pilot Study of Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection in Kidney Transplantation
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 19 Apr 2018 Biomarkers information updated
- 01 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 21 Mar 2013 Planned End Date changed from 1 Jul 2014 to 1 May 2015 as reported by ClinicalTrials.gov.